Bluewater Bio

Bluewater Bio is an award-winning global leader in sustainable water and wastewater treatment, offering proprietary next-generation technologies designed to use significantly less energy, land, and chemicals than conventional alternatives. The company's portfolio includes HYBACS (an enhanced activated sludge process), FilterClear (high-throughput multi-media filtration), and CFIC (a next-generation moving bed bioreactor technology), all proven at utility scale across municipal and industrial applications. Recognised by the Financial Times as Europe's Long Term Growth Champions for two consecutive years and recipient of both the Queen's Award and King's Award for Enterprise, Bluewater Bio serves clients across desalination, municipal wastewater, industrial wastewater, and water reuse markets globally. In 2026, the company secured a significant majority investment from Verdane and Scott Capital Partners to accelerate international expansion.